Foxo Technologies Inc
FOXO0.152USD
-0.004-2.69%
시장 운영 시간 （ET）시세는 15분 지연됩니다
52.04K시가총액
손실P/E TTM
자세한 내용은 Foxo Technologies Inc 회사
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
회사 정보
종목 코드 FOXO
회사 이름Foxo Technologies Inc
상장일Dec 11, 2020
CEOMr. Seamus Lagan
직원 수- -
유형Ordinary Share
회계 연도 종료Dec 11
주소477 South Rosemary Avenue
도시WEST PALM BEACH
증권 거래소NYSE American Consolidated
국가United States of America
우편 번호33401
전화16128000059
웹사이트http://delwinds.com/
종목 코드 FOXO
상장일Dec 11, 2020
CEOMr. Seamus Lagan
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
167.00
--
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Bret Barnes
Mr. Bret Barnes
Independent Chairman of the Board
Independent Chairman of the Board
167.00
--
Dr. Murdoc Khaleghi, M.D.
Dr. Murdoc Khaleghi, M.D.
Independent Director
Independent Director
--
--
Mr. Matthew Hausch
Mr. Matthew Hausch
IR Contact Officer
IR Contact Officer
--
--
Mr. Seamus Lagan
Mr. Seamus Lagan
Chief Executive Officer, Interim Chief Financial Officer, Director
Chief Executive Officer, Interim Chief Financial Officer, Director
--
--
Mr. Trevor Langley
Mr. Trevor Langley
Director
Director
--
--
Mr. Francis Colt Dewolf, III
Mr. Francis Colt Dewolf, III
Independent Director
Independent Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
주주
주주 유형
주주
주주
비율
Rennova Health, Inc.
0.96%
Clearthink Capital Partners LLC
0.56%
Kr8 ai Inc
0.22%
UBS Financial Services, Inc.
0.14%
Geode Capital Management, L.L.C.
0.14%
Other
97.97%
주주
주주
비율
Rennova Health, Inc.
0.96%
Clearthink Capital Partners LLC
0.56%
Kr8 ai Inc
0.22%
UBS Financial Services, Inc.
0.14%
Geode Capital Management, L.L.C.
0.14%
Other
97.97%
주주 유형
주주
비율
Corporation
1.75%
Investment Advisor
0.21%
Investment Advisor/Hedge Fund
0.17%
Research Firm
0.05%
Hedge Fund
0.03%
Other
97.80%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
42
117.55K
2.20%
-40.11K
2025Q1
44
283.42K
16.93%
-74.76K
2024Q4
45
2.97M
12.59%
-305.11K
2024Q3
42
2.93M
22.70%
-1.57M
2024Q2
66
3.17M
26.93%
-1.03M
2024Q1
108
4.13M
45.76%
-1.73M
2023Q4
115
3.33M
41.62%
-1.13M
2023Q3
119
2.33M
33.97%
-1.67M
2023Q2
124
2.96M
79.90%
-804.39K
2023Q1
129
1.99M
69.67%
-1.77M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Rennova Health, Inc.
102.36K
0.96%
-1.00
-0.00%
May 21, 2025
Clearthink Capital Partners LLC
60.00K
0.56%
+60.00K
--
Dec 01, 2023
Kr8 ai Inc
23.70K
0.22%
-1.00
-0.00%
May 21, 2025
UBS Financial Services, Inc.
15.02K
0.14%
+1.03K
+7.33%
Mar 31, 2025
Geode Capital Management, L.L.C.
14.40K
0.14%
+10.16K
+239.24%
Mar 31, 2025
SBI Securities Co., Ltd.
5.10K
0.05%
+1.17K
+29.67%
Mar 31, 2025
Corbin Capital Partners, L.P.
2.75K
0.03%
--
--
Dec 31, 2024
Capital Investment Advisory Services, LLC
2.50K
0.02%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
2.42K
0.02%
--
--
Mar 31, 2025
State Street Global Advisors (US)
2.00K
0.02%
--
--
Mar 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
날짜
유형
비율
Nov 15, 2024
Merger
0<0
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
Oct 30, 2023
Merger
10<1
